Company intelligence / Profile preview

Nang Kuang Pharmaceutical Co., Ltd.

Ownership: Private
Employees: ~552
Development stage: Commercial

Overview

The firm appears primarily manufacturing/trading oriented rather than an innovative biotech developer but has at least one early phase clinical program underway related to postoperative pain/inflammation treatment via intravenous route indicating some R&D activity beyond pure manufacturing.

Therapeutic areas: GastroenterologyPulmonologyCardiovascularRheumatologyOncologyNeurology
Modalities: Small moleculesinjectablescapsulescreams
Industry: Contract Manufacturing Organization

Partnerships

Fresenius KabiOrion PharmaFerrerEsteve

Beyond the preview

Go deeper on Nang Kuang Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nang Kuang Pharmaceutical Co., Ltd..

Explore the full profile